Found 0 matching trials
A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321 PHASE1 This is a single centre, three single administrations (Days 1, 29 and 57) a...
Show More Learn More & Join Trial
Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure. NA This was a non-blinded, prospective clinical study. From June 2020 to Octob...
Show More Location
Xiangya Hospital of Central South University
Learn More & Join Trial
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus N/A 296 million people worldwide are infected with the hepatitis B virus (HBV),...
Show More Location
Hôpital Saint Louis AP-HP
Learn More & Join Trial
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients PHASE4 This 48-week open-label study of local manufactured adefovir dipivoxil Tabl...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function PHASE4 A double-blind randomized, parallel, multicenter with 48 weeks of treatment...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) PHASE4 To Identify the collected cases who can stop NAs safely with satisfactory c...
Show More Location
Humanity & Health Research Centre
Learn More & Join Trial
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection PHASE2 NAPs have been previously shown to clear serum hepatitis B virus surface an...
Show More Location
Infectious Clinical Hospital (n.a. Toma Ciorba) Department 5
Learn More & Join Trial
The Mechanistic Biology of Primary Immunodeficiency Disorders N/A Background:
Primary immunodeficiency disorders, or PIDs, are diseases that...
Show More Location
Children's National Health System (CNHS)
Learn More & Join Trial
Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults PHASE1 Primary Objective:
• To evaluate the safety and tolerability of cAd3-EBO-S...
Show More Location
Oklahoma Blood Institute (OBI)
Learn More & Join Trial
Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine PHASE4 In this study, subjects who received primary neonatal vaccination with hepa...
Show More Location
GSK Investigational Site
Learn More & Join Trial